Low-Dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms

Low-Dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms

Thromboembolism is one of the major complications of stent assisted coiling in treatment of cerebral aneurysm. Clopidogrel resistance is so common and prasugrel is more effective in its rapid and potent effect. We investigated changes in the value of P2Y12 resistance unit (PRU) when prasugrel was ad...

Full description

Bibliographic Details
Main Authors:	Dongwhane Lee, Yunsun Song, Minkyu Han, Danbi Park, Dae Chul Suh
Format:	Article
Language:	English
Published:	Korean Society of Interventional Neuroradiology 2018-09-01
Series:	Neurointervention
Subjects:	prasugrel hydrochloride clopidogrel platelet aggregation inhibitors drug resistance intracranial aneurysm
Online Access:	http://neurointervention.org/upload/pdf/neuroint-2018-01088.pdf

Similar Items

Comparision Between Clopidogrel and Prasugrel On hs-CRP Levels Post Percutaneous Intervention
by: A. Ashok Kumar, et al.
Published: (2017-03-01)

Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
by: Jan Kiebist, et al.
Published: (2021-09-01)

Clopidogrel resistance: The way forward
by: Shuvanan Ray
Published: (2014-09-01)

Prasugrel
by: Gianluca Airoldi, et al.
Published: (2013-04-01)

Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE‐ACS) Study
by: Amit N. Vora, et al.
Published: (2016-09-01)

Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis
by: Pravesh Kumar Bundhun, et al.
Published: (2018-05-01)

Low-dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms: Follow-up of over 6 Months
by: Dongwhane Lee, et al.
Published: (2019-03-01)

Effects of Ramadan fasting on platelet reactivity in diabetic patients treated with clopidogrel
by: W. Bouida, et al.
Published: (2017-06-01)

Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy
by: Abdullah M. Al-Rubaish, et al.
Published: (2020-06-01)

Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013
by: O. V. Averkov
Published: (2013-02-01)

Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial
by: Sarah Baos, et al.
Published: (2017-11-01)

The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
by: John I. Louca, et al.
Published: (2014-09-01)

Puncture site bleeding complications in patients with Clopidogrel hyper-response
by: Nedeljković Žarko, et al.
Published: (2020-03-01)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
by: Viviana Laredo, et al.
Published: (2020-05-01)

Staged Approach for Stent-Assisted Coiling of Cerebral Aneurysms after Failure of Initial Intra-Saccular Catheterization
by: Abdulrahman Hamad Al-Abdulwahhab, et al.
Published: (2021-03-01)

Timing and Spectrum of Neurological Complications After Flow Diverter Implantation for Intracranial Aneurysms
by: Guillaume Charbonnier, et al.
Published: (2021-04-01)

A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
by: Wun Ted, et al.
Published: (2013-02-01)

Clopidogrel resistance in patients with acute coronary syndrome
by: N S Frolova, et al.
Published: (2010-08-01)

Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
by: Mshelbwala FS, et al.
Published: (2020-04-01)

The effectiveness, side effects and acceptability of locally available brand of Clopidogrel (Osvix) as antiplatelet tablet in CABG patients
by: Behzad Imani, et al.
Published: (2014-07-01)

Assessment of efficacy of single dose acetylsalicylic acid over a 24-hour period
by: Reşat Mehmet Baha, et al.
Published: (2015-07-01)

Safety of Prasugrel in Indian patients – Multicentric registry of 1000 cases
by: Upendra Kaul, et al.
Published: (2014-11-01)

Relevancia clínica de la interacción clopidogrel y omeprazol: revisión sistemática Clinical relevance of clopidogrel and omeprazole interaction: systematic review
by: Héctor Holguín, et al.
Published: (2012-01-01)

The influence of diabetic status on the pharmacokinetics of clopidogrel and its metabolites in patients suffered from cardiovascular diseases
by: Marta Karaźniewicz-Łada, et al.
Published: (2014-09-01)

In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris
by: Rza Hajizadeh, et al.
Published: (2017-12-01)

THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY
by: V. V. Yakusevich, et al.
Published: (2016-01-01)

De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature
by: Daniel MF Claassens, et al.
Published: (2020-09-01)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
by: Zhe Wang, et al.
Published: (2020-03-01)

P2Y<sub>12</sub> Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel
by: N. M. Vorobyeva
Published: (2019-01-01)

The comparison between the effects of aspirin and clopidogrel monotherapy on postoperative bleeding in diabetic patients after off-pump coronary artery bypass surgery
by: Levent Altınay, et al.
Published: (2021-09-01)

A brief review on resistance to P2Y12 receptor antagonism in coronary artery disease
by: Ellen M. K. Warlo, et al.
Published: (2019-05-01)

Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis
by: Xiaojun Zhuo, et al.
Published: (2018-09-01)

Antithrombotic Therapy in Patients with Coronary Artery Disease and Prior Stroke
by: Elisa Bellettini, et al.
Published: (2021-04-01)

Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysis
by: Ke An, et al.
Published: (2019-05-01)

WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME
by: M. Yu. Gilyarov, et al.
Published: (2018-05-01)

Cytochrome P450 et inflammation : approche pharmacogénomique et aspects moleculaires des effets anti-inflammatoires des thiénopyridines
by: Shahabi, Payman
Published: (2013)

Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview
by: Hillegass B
Published: (2011-07-01)

Double antiplatelet therapy in patients with acute coronary syndrome
by: A. V. Rodionov, et al.
Published: (2011-10-01)

TRimetazidine as an Agent to affeCt clopidogrEl Response: The TRACER Study
by: Naveen Seecheran, et al.
Published: (2019-07-01)

Comparison of Efficacy between Clopidogrel and Ticagrelor in Patients with Acute Coronary Syndrome after Interventional Treatment and Their Effects on IL-6
by: Bin YANG, et al.
Published: (2020-02-01)